Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100
NCT01188850
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Papillomavirus (HPV)
Interventions
BIOLOGICAL:
VGX-3100
Sponsor
Inovio Pharmaceuticals